Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Microbiology 152 (2006), 143-152; DOI  10.1099/mic.0.28368-0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shaver, C. M.
Right arrow Articles by Hauser, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shaver, C. M.
Right arrow Articles by Hauser, A. R.
Agricola
Right arrow Articles by Shaver, C. M.
Right arrow Articles by Hauser, A. R.
Microbiology 152 (2006), 143-152; DOI  10.1099/mic.0.28368-0
© 2006 Society for General Microbiology

Interactions between effector proteins of the Pseudomonas aeruginosa type III secretion system do not significantly affect several measures of disease severity in mammals

Ciara M. Shaver1 and Alan R. Hauser1,2

1 Department of Microbiology-Immunology, Northwestern University Feinberg School of Medicine, 303 East Chicago Avenue, Searle 6-495, Chicago, IL 60611, USA
2 Department of Medicine, Northwestern University Feinberg School of Medicine, 303 East Chicago Avenue, Searle 6-495, Chicago, IL 60611, USA

Correspondence
Alan R. Hauser
ahauser{at}northwestern.edu

The effector proteins of the type III secretion systems of many bacterial pathogens act in a coordinated manner to subvert host cells and facilitate the development and progression of disease. It is unclear whether interactions between the type-III-secreted proteins of Pseudomonas aeruginosa result in similar effects on the disease process. We have previously characterized the contributions to pathogenesis of the type-III-secreted proteins ExoS, ExoT and ExoU when secreted individually. In this study, we extend our prior work to determine whether these proteins have greater than expected effects on virulence when secreted in combination. In vitro cytotoxicity and anti-internalization activities were not enhanced when effector proteins were secreted in combinations rather than alone. Likewise in a mouse model of pneumonia, bacterial burden in the lungs, dissemination and mortality attributable to ExoS, ExoT and ExoU were not synergistically increased when combinations of these effector proteins were secreted. Because of the absence of an appreciable synergistic increase in virulence when multiple effector proteins were secreted in combination, we conclude that any cooperation between ExoS, ExoT and ExoU does not translate into a synergistically significant enhancement of disease severity as measured by these assays.


Abbreviations: ADPRT, ADP-ribosyltransferase; GAP, GTPase-activating protein; LDH, lactate dehydrogenase




This article has been cited by other articles:


Home page
Infect. Immun.Home page
M. H. Diaz, C. M. Shaver, J. D. King, S. Musunuri, J. A. Kazzaz, and A. R. Hauser
Pseudomonas aeruginosa Induces Localized Immunosuppression during Pneumonia
Infect. Immun., October 1, 2008; 76(10): 4414 - 4421.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
H.-H. Lin, S.-p. Huang, H.-C. Teng, D.-D. Ji, Y.-S. Chen, and Y.-L. Chen
Presence of the exoU Gene of Pseudomonas aeruginosa Is Correlated with Cytotoxicity in MDCK Cells but Not with Colonization in BALB/c Mice
J. Clin. Microbiol., December 1, 2006; 44(12): 4596 - 4597.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2006 Society for General Microbiology.